YMAB
NASDAQ
$8.61
Y-Mabs Therapeutics Inc (YMAB)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$390M
Free Cash Flow Yield
-4.59%
Price Chart
Valuation
Market Cap$390M
P/S4.57
P/B4.46
Profitability
Total Revenue (TTM)$85M
EBITDA-$26M
Profit Margin-16.6%
Operating Margin-28.7%
EPS-$0.50
Financial Health
Debt-to-Equity3.7%
Free Cash Flow Yield-4.59%
Growth & Risk
Sharpe Ratio0.04